Compare TSCO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSCO | MEDP |
|---|---|---|
| Founded | 1938 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1B | 17.2B |
| IPO Year | 1996 | 2016 |
| Metric | TSCO | MEDP |
|---|---|---|
| Price | $36.81 | $665.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 30 | 14 |
| Target Price | $37.48 | ★ $651.31 |
| AVG Volume (30 Days) | ★ 14.0M | 301.9K |
| Earning Date | 10-22-2026 | 10-21-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | 0.98 | ★ 20.98 |
| EPS | 1.43 | ★ 13.37 |
| Revenue | ★ $15,524,046,000.00 | N/A |
| Revenue This Year | $3.48 | $12.62 |
| Revenue Next Year | $3.88 | $6.03 |
| P/E Ratio | ★ $26.30 | $49.82 |
| Revenue Growth | ★ 4.31 | N/A |
| 52 Week Low | $28.36 | $373.00 |
| 52 Week High | $56.94 | $693.97 |
| Indicator | TSCO | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 63.17 | 55.31 |
| Support Level | $29.40 | $575.64 |
| Resistance Level | $46.00 | $685.94 |
| Average True Range (ATR) | 1.33 | 20.42 |
| MACD | 0.38 | -1.35 |
| Stochastic Oscillator | 86.64 | 50.11 |
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. As of July 2026, the company operated 2,463 of its namesake banners in 49 states, along with 209 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2025, revenue consisted of livestock, equine & agriculture (around 27%); companion animal (24%); seasonal & recreation (around 24%); truck, tool, & hardware (15%); and clothing, gift, and décor (10%).
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.